Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Complex Partial Epilepsy

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Complex Partial Epilepsy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa, DC; Ell, PJ; George, MS; Ring, HA; Trimble, MR; Verhoeff, P1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Complex Partial Epilepsy

ArticleYear
Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:9

    Topics: Adolescent; Adult; Aminocaproates; Anticonvulsants; Benzamides; Child; Child, Preschool; Corpus Striatum; Epilepsies, Myoclonic; Epilepsy, Complex Partial; Female; Humans; Iodine Radioisotopes; Male; Pyrrolidines; Receptors, Dopamine; Receptors, GABA-A; Tomography, Emission-Computed, Single-Photon; Vigabatrin

1992